AGT researchers net $4.4m NIH grant
Thursday, 03 July, 2003
Researchers associated with Victorian-based AGT Biosciences have landed a $AUD4.4 million grant from the US National Institutes of Health to fund its human gene discovery research.
The grant, awarded over a period of five years, will be shared between Prof Ahmed Kissebah of the Medical College of Wisconsin, Dr John Blangero of AGT and the Texas-based Southwest Foundation for Biomedical Research, and the AGT team at Deakin University, Geelong.
Prof Greg Collier, AGT's CEO and managing director, said in a statement that the grant was a strong affirmation of AGT's approach to solving problems of complex human diseases.
He said the grant would support a trilateral collaboration between Kissebah (population genetics), Blangero's team (statistical genomics) and AGT's eXpress technology platform.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
